SCHEMBL1066142

SCHEMBL1066142

CCC1CCc2c(sc(NC(=O)c3ccc(OC)cc3)c2C(N)=O)C1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.68
KDM4E B2RXH2 5/20 0.68
ALDH1A1 P00352 4/20 0.68
RAB9A P51151 4/20 0.68
MAPT P10636 4/20 0.65
KMT2A Q03164 4/20 0.65
MEN1 O00255 3/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
NPC1 O15118 2/20 0.65
TP53 P04637 1/20 0.65
HTT P42858 1/20 0.65
HPGD P15428 3/20 0.64
THRB P10828 1/20 0.64
USP2 O75604 1/20 0.64
XBP1 P17861 1/20 0.64
HSD17B10 Q99714 1/20 0.64
TNIK Q9UKE5 1/20 0.62
AIP O00170 1/20 0.62
SGTA O43765 1/20 0.62
TOMM70 O94826 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8290603 0.78 ALDH1A1 (0.72) FLT3KDM4EALDH1A1RAB9AMAPT
SCHEMBL5451446 0.76 AIP (0.71) FLT3KDM4EALDH1A1RAB9AMAPT
SCHEMBL5453282 0.76 AIP (0.71) FLT3KDM4EALDH1A1RAB9AMAPT
SCHEMBL21247230 0.75 THRB (0.79) FLT3KDM4EALDH1A1RAB9AMAPT
SCHEMBL21247250 0.75 THRB (0.68) FLT3KDM4EALDH1A1RAB9AMAPT
SCHEMBL5460515 0.75 AIP (0.69) KDM4EALDH1A1RAB9AMAPTKMT2A
SCHEMBL23657531 0.74 ALDH1A1 (0.69) KDM4EALDH1A1RAB9AMAPTKMT2A
SCHEMBL5453529 0.74 TNIK (0.59) FLT3MAPTTNIK
SCHEMBL2182372 0.74 TP53 (0.80) FLT3KDM4EALDH1A1RAB9AMAPT
SCHEMBL1067537 0.73 ALDH1A1 (0.80) KDM4EALDH1A1RAB9AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222326-B2 INHIBITORS OF MALT1 PROTEOLYTIC ACTIVITY AND USES THEREOF VIB VZW (BE) 2015-02-25 EP disclosed
EP-2222326-B1 Inhibitors of MALT1-proteolytic activity and uses thereof VIB VZW (BE) 2012-04-18 EP disclosed
US-20110021548-A1 INHIBITORS OF MALT1 PROTEOLYTIC ACTIVITY AND USES THEREOF UNIVERSITEIT GENT (BE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021548-A1 INHIBITORS OF MALT1 PROTEOLYTIC ACTIVITY AND USES THEREOF MMEL1, CTRL, ZFR FLT3 4205/4885KDM4E 566/4885ALDH1A1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.